Biotech

All Articles

Ideaya bags possibility on Biocytogen bispecific ADC in $400M deal

.Ideaya Biosciences is actually wagering $400 million in biobucks that a bispecific antibody-drug co...

Takeda takes $140M loss on neglected epilepsy medicine, boasts FDA manage

.We presently know that Takeda is intending to find a pathway to the FDA for epilepsy medication sot...

VBI Injections files for bankruptcy, finds possession purchase

.Immunology biotech VBI Vaccines is diverting precariously near the moment of truth, along with plan...

Celldex anti-cKIT antitoxin lower colonies in an additional period 2 research

.It is actually difficult to muscle in on a space as very competitive as immunology, however Celldex...

Boehringer provides to $1.3 B for gate prevention biotech

.Boehringer Ingelheim is providing to $1.3 billion for Nerio Therapies and also a preclinical invuln...

Ventyx's last hope for inflammatory med ends in Crohn's breakdown

.Ventyx Biosciences' Crohn's health condition medication performed not help patients accomplish remi...

Cognition's period 2 sparkle data blemish Alzheimer's possibility

.Cognition Therapies' stage 2 luster test has actually taken a number of the radiance off the Alzhei...

BMS axes bispecific months after submitting to run stage 3 test

.Bristol Myers Squibb has possessed a whiplash change of heart on its own BCMA bispecific T-cell eng...

Charles Baum manages Terremoto as CEO

.Charles Baum, M.D., Ph.D., who looked after Mirati Therapies' $ 5.8 billion purchase to Bristol Mye...

Asarina to close after initiatives to partner Tourette's medication stop working

.After connecting to more than 200 companies to companion a Tourette syndrome therapy that showed th...